Analyst Says This Small Cap Biotech Firm Has ‘Very Valuable Therapeutic,’ Upgrades Stock
Raymond James has upgraded Dyne Therapeutics Inc (NASDAQ:DYN) from Outperform to Strong Buy and raised the price target to $27 from $16.…
LumiraDx Gets FDA Emergency Use Authorization Amendment For Its LumiraDx SARS-CoV-2 RNA Star Complete Test Kit To Extend The Shelf Life To 12 Months
https://www.fda.gov/media/165719/download
Astrazeneca Announces Major Investment In Ontario’s Life Sciences Sector
Investment brings 500 scientific and high-tech jobs to the Greater Toronto Area
MISSISSAUGA, ON, Feb. 27, 2023 /CNW/ - AstraZeneca is pleased to announce it is bringing 500 highly-skilled scientific
Analyst Cautions Investors On Overreacting To ‘Early-Stage’ Pfizer/Seagen Discussions
In a news article by the Wall Street Journal, Pfizer Inc (NYSE:PFE) is reportedly in early-stage talks to acquire Seagen Inc (NASDAQ:SGEN) for…
Why Reata Pharmaceuticals Shares Are Falling Monday?
According to various reports, the FDA's neuroscience expert Billy Dunn is leaving the agency after more than 15 years, effective immediately.
Shionogi’s COVID-19 Pill, Based On Similar Action Like Pfizer’s, Sees Around $2B In Annual Sales
Japanese pharmaceutical company Shionogi & Co Ltd's CEO believes its COVID-19, Xocova, pill can generate $2 billion in annual sales if it secures FDA approval.
The company expects U.S. approval by late 2024.
TransCode Therapeutics Gets Orphan Designation Status On Dextran-Coated, Nanoparticle-Conjugated Stabilized Synthetic Antisense Oligonucleotide Targeting miR-10b For The Treatment Of Pancreatic Cancer
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=926622
Jaguar Health Subsidiary Napo Pharmaceuticals Inc. Gets FDA Orphan Drug Designation For Crofelemer For Treatment Of Microvillus Inclusion Disease
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=897722
Biophytis Seeks Early Access Authorization For Its COVID-19 Treatment In France
Biophytis SA (NASDAQ:BPTS) has begun the early access application process in France for Sarconeos (BIO101) for the treatment of severe COVID-19.…
Hyperfine Has Been Granted FDA 510k Clearance For The Swoop Portable MR Imaging System
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K230208